Stockscreener 앱 받기
89.69
4.61%
3.95
시간 외 거래:
90.00
0.31
+0.35%
전일 마감가:
$85.74
열려 있는:
$87
하루 거래량:
223.70K
Relative Volume:
1.09
시가총액:
$4.11B
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+5.33%
1개월 성능:
-9.54%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$85.00
$90.00
1주일 범위
$84.14
$98.26
52주 변동 폭
$80.00
$138.70
Billiontoone Inc Stock (BLLN) Company Profile
Compare BLLN vs TMO, DHR, IDXX, A, WAT
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BLLN
Billiontoone Inc
|
89.69 | 3.92B | 0 | 0 | 0 | 0.00 |
|
TMO
Thermo Fisher Scientific Inc
|
509.82 | 198.06B | 44.56B | 6.73B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
214.94 | 155.50B | 24.57B | 3.60B | 5.25B | 5.0475 |
|
IDXX
Idexx Laboratories Inc
|
617.20 | 51.80B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
124.88 | 36.46B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
WAT
Waters Corp
|
319.83 | 32.29B | 3.17B | 642.63M | 539.81M | 10.77 |
Billiontoone Inc Stock (BLLN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-06 | 개시 | Guggenheim | Buy |
| 2025-12-01 | 개시 | BTIG Research | Buy |
| 2025-12-01 | 개시 | JP Morgan | Overweight |
| 2025-12-01 | 개시 | Jefferies | Hold |
| 2025-12-01 | 개시 | Piper Sandler | Overweight |
| 2025-12-01 | 개시 | Stifel | Buy |
| 2025-12-01 | 개시 | Wells Fargo | Equal Weight |
| 2025-12-01 | 개시 | William Blair | Outperform |
모두보기
Billiontoone Inc 주식(BLLN)의 최신 뉴스
BillionToOne expands liquid biopsy platform with two add-on tests By Investing.com - Investing.com South Africa
BillionToOne Expands Northstar Platform with Launch of Two New Add-On Liquid Biopsy Applications for Northstar Select - Finviz
BillionToOne, Inc. Expands Northstar Platform with Launch of Two New Add-On Liquid Biopsy Applications for Northstar Select - marketscreener.com
BillionToOne expands liquid biopsy platform with two add-on tests - Investing.com
BillionToOne Expands Northstar Platform with Launch of Two New A - GuruFocus
BillionToOne Expands Northstar Platform with Launch of Two New Add-On Liquid Biopsy Applications for Northstar Select® - PR Newswire
BillionToOne Announces Dual Launch of UNITY Expanded Red Blood Cell and Platelet Fetal Antigen NIPTs, Extending Its Leadership In Setting the New Standard in Prenatal Care - BioSpace
BillionToOne Expands Leadership in HDFN and FNAIT Testing - Intellectia AI
BillionToOne Leads 3 Value Stock Picks That May Offer Investment Opportunities - Yahoo Finance
BillionToOne Inc (BLLN) Shares Up 2.91% on Feb 2 - GuruFocus
Analysts Offer Insights on Healthcare Companies: Upstream Bio, Inc. (UPB) and BillionToOne, Inc. Class A (BLLN) - The Globe and Mail
BillionToOne, Inc. Completes Successful IPO Raising $314 Million - MSN
BillionToOne Inc (BLLN) Shares Up 3.56% on Jan 27 - GuruFocus
Billiontoone (NASDAQ:BLLN) Trading 6.3% HigherStill a Buy? - MarketBeat
Assessing BillionToOne (BLLN) Valuation After Recent Share Price Pullback - Yahoo Finance
Assessing BillionToOne (BLLN) Valuation As Mixed Recent Returns Meet Conflicting Growth Expectations - simplywall.st
BillionToOne Inc (BLLN) Shares Up 7.3% on Jan 22 - GuruFocus
Billiontoone (NASDAQ:BLLN) Sets New 1-Year LowWhat's Next? - MarketBeat
Analysts Offer Insights on Healthcare Companies: BillionToOne, Inc. Class A (BLLN) and Dexcom (DXCM) - The Globe and Mail
BillionToOne Inc (BLLN) Trading Down 4.99% on Jan 20 - GuruFocus
Billiontoone, Inc. (NASDAQ:BLLN) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
BillionToOne Inc (BLLN) Stock Price Down 3.55% on Jan 16 - GuruFocus
BillionToOne integrates prenatal and oncology tests with Epic EHR By Investing.com - Investing.com Nigeria
BillionToOne Integrates Prenatal and Oncology Tests into Epic Aura Diagnostics Suite - TipRanks
BillionToOne to Integrate Testing Portfolio With Epic's Diagnostics Suite - marketscreener.com
BillionToOne Announces Collaboration with Epic to Expand Prenata - GuruFocus
BillionToOne, Inc. Announces Collaboration with Epic to Expand Prenatal and Oncology Testing Across Healthcare - marketscreener.com
BillionToOne integrates prenatal and oncology tests with Epic EHR - Investing.com
BillionToOne Announces Collaboration with Epic to Expand Prenatal and Oncology Testing Across Healthcare - PR Newswire
Billiontoone (NASDAQ:BLLN) Stock Price Down 6%Here's What Happened - MarketBeat
What's Going On With BillionToOne Shares Tuesday? - Benzinga
BillionToOne reaffirms 2025 guidance, projects 40-45% revenue growth in 2026 - Investing.com Nigeria
BillionToOne Stock (+15%): Strong '26 Guidance Spurs Re-Rate - Trefis
BillionToOne: Reaffirmed Growth Targets and Upside to 2026 Support Reiterated Buy Rating - TipRanks
BillionToOne reaffirms FY25 guidance - MSN
(BLLN) BillionToOne Expects 2026 Total Revenue Range $415M to $430M, vs. FactSet Est of $402.3M - marketscreener.com
BillionToOne Issues Strong 2026 Growth and Profit Outlook - TipRanks
Billiontoone provides guidance for 2026 - marketscreener.com
BillionToOne Provides Guidance for 2026 - The Manila Times
Billiontoone Provides Guidance For 2026 - TradingView — Track All Markets
BillionToOne, Inc. (NASDAQ:BLLN) Q3 2025 earnings call transcript - MSN
BillionToOne initiated with a Buy at Stifel - MSN
BillionToOne, Inc.: Revenue and Earnings Analysts Forecasts Revisions | BPJH | US0901681058 - marketscreener.com
January 2026's Top Growth Companies With Insider Confidence - Yahoo Finance
After tax other income/expense of BillionToOne, Inc. Class A – BX:BLLN - TradingView — Track All Markets
Billiontoone (NASDAQ:BLLN) Now Covered by Guggenheim - MarketBeat
BillionToOne initiated with a buy at Guggenheim - MSN
BillionToOne, Inc. Announces Selection of Northstar Select as New Liquid Biopsy Test for LC-SCRUM-TRY Clinical Study at National Cancer Center Hospital East - marketscreener.com
Billiontoone Inc (BLLN) 재무 분석
Billiontoone Inc (BLLN)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
1.18%
자본화:
|
볼륨(24시간):